How COVID unlocked the power of RNA vaccines
Elie Dolgin • January 12, 2021
The technology could revolutionize efforts to immunize against HIV, malaria, influenza and more.
The era of RNA vaccines has arrived — and dozens of companies are getting in the game.
Read more at Nature.
With organoids, assembloids and a growing bioengineering toolkit, scientists are pushing the limits of human brain models.
Drug makers are scrambling to navigate an ‘existential threat’ to a once-celebrated technology.